Literature DB >> 2453240

Endothelium-dependent hyperpolarization of canine coronary smooth muscle.

M Feletou1, P M Vanhoutte.   

Abstract

1. Experiments were designed to determine whether endothelium-dependent relaxing factor(s) released by acetylcholine from the canine femoral artery influences the membrane potential of coronary arterial smooth muscle. 2. The membrane potential was recorded in small canine coronary arteries (internal diameter less than or equal to 500 micron; without endothelium) by means of intracellular microelectrodes. The organ bath also contained a strip of left descending coronary artery without endothelium in which isometric force was measured to bioassay relaxing factor(s) as well as segments of femoral artery with endothelium, which served as the source of endothelium-derived relaxing factor(s). 3. Acetylcholine induced endothelium-dependent, transient hyperpolarizations and relaxations that were not affected by indomethacin. 4. Inhibition of the sodium-potassium pump by ouabain or potassium-free solution did not inhibit the relaxation to acetylcholine but prevented the corresponding hyperpolarization. 5. Activation of the sodium-potassium pump of the smooth muscle cells by readmission of potassium ions after incubation in potassium-free solution caused relaxation and marked hyperpolarization. 6. These results suggest that endothelium-derived relaxing factor(s) induces hyperpolarization of vascular smooth muscle of the canine coronary artery, possibly by activation of sodium-potassium pumping, but that this effect on the cell membrane may only partially explain endothelium-dependent relaxations evoked by acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453240      PMCID: PMC1853853          DOI: 10.1111/j.1476-5381.1988.tb10306.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Authors:  S Moncada; J R Vane
Journal:  Pharmacol Rev       Date:  1978-09       Impact factor: 25.468

2.  Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries.

Authors:  D R Harder; L Belardinelli; N Sperelakis; R Rubio; R M Berne
Journal:  Circ Res       Date:  1979-02       Impact factor: 17.367

3.  Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle.

Authors:  T B Bolton; L H Clapp
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

4.  Cardiac glycoside stimulation of inward Ca++ current in vascular smooth muscle of canine coronary artery.

Authors:  L Belardinelli; D Harder; N Sperelakis; R Rubio; R M Berne
Journal:  J Pharmacol Exp Ther       Date:  1979-04       Impact factor: 4.030

5.  Mechanism of inhibition of smooth muscle tension in guinea-pig taenia coli by ouabain.

Authors:  D Bose
Journal:  Can J Physiol Pharmacol       Date:  1974-08       Impact factor: 2.273

Review 6.  The electrogenic Na+, K+-pump in smooth muscle: physiologic and pharmacologic significance.

Authors:  W W Fleming
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

7.  Interaction between Na+,K+ exchanges and the direct inhibitory effect of acetylcholine on canine femoral arteries.

Authors:  J G De Mey; P M Vanhoutte
Journal:  Circ Res       Date:  1980-06       Impact factor: 17.367

8.  The effects of acetylcholine on the membrane and contractile properties of smooth muscle cells of the rabbit superior mesenteric artery.

Authors:  H Kuriyama; H Suzuki
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

9.  Effects of acetylcholine on the smooth muscle cell of isolated main coronary artery of the guinea-pig.

Authors:  K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1979-08       Impact factor: 5.182

10.  Effects of acetylcholine and catecholamines on the smooth muscle cell of the porcine coronary artery.

Authors:  Y Ito; K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

View more
  139 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

Review 2.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Endothelium derived relaxing factor/nitric oxide.

Authors:  G Blaise
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 4.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 5.  CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.

Authors:  Modar Kassan; Andrea Wecker; Philip Kadowitz; Mohamed Trebak; Khalid Matrougui
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

6.  Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide).

Authors:  A H Huang; R Busse; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

7.  Cyclic GMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery.

Authors:  D M Eckman; J S Weinert; I L Buxton; K D Keef
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle.

Authors:  H C Parkington; M A Tonta; H A Coleman; M Tare
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

9.  Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.

Authors:  S M Yu; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.